... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Consensus statement Dermatophytosis Efficacy Itraconazole Onychomycosis Safety...

... hematoma Subungual melanoma Subungual nevus Onychomycosis Imaging method Noninvasive diagnosis Subungual hematomas are often incidental findings [1-3]. However, they are, at times, a diagnostic challenge to clinicians, especially when their genesis is unclear [1-3]. The indications...

.... Trichophyton violaceum Tinea capitis Tinea corporis Onychomycosis Dermatophytosis Treatment Terbinafine Griseofulvine Research Article Dermatology 2019;235:434 439 DOI: 10.1159/000501271 Received: February 21, 2019 Accepted after revision: May 30, 2019 Published online: July 11, 2019 Trichophyton...

...Chao Liu; Ling Zhang; Hai-Yan Zeng; Hong Bei; Shi-Ping Chen; Yi-Xi Wu; Wen-Xia Luo; Qing Fang; Pin-Mei Liu Background: No optimal regimen exists for the LPNYL (long-pulsed 1,064-nm neodymium:yttrium-aluminum-garnet laser) for treating onychomycosis. Objective: To establish an optimal LPNYL...

...Bianca Maria Piraccini; Michela Starace; Anders Toft Introduction: Onychomycosis and nail psoriasis can be embarrassing to patients, so improving the appearance of affected nails should be one of the key short-term goals of treatment. Methods: An 8-week open-label multicenter study was conducted...

...Regina Renner; Kathrin Grüßer; Michael Sticherling Background: Onychomycosis is one of the most prevalent nail disorders in adults, where conventional topical therapy is often protracted and in most cases ineffective. On the other hand, systemic/oral therapy is not suitable for all patients...

...Aditya K. Gupta; Fiona C. Simpson; William C. Brintnell Background: The variability in susceptibility to onychomycosis for individuals exposed to the same environmental risk factors raises the possibility that there may be individuals with a genetic predisposition to dermatophyte infection...

...Julie Verrier; Olympia Bontems; Florence Baudraz-Rosselet; Michel Monod Background: Fusarium onychomycoses are weakly responsive or unresponsive to standard onychomycosis treatments with oral terbinafine and itraconazole. Objective: To examine whether the use of terbinafine and itraconazole, which...

... the efficacy and safety of a sequential (SEQ) treatment with chemical nail avulsion and topical antifungals to amorolfine nail lacquer in dermatophytic onychomycosis. Methods: This was a randomized, parallel-group, controlled study comparing a 36-week SEQ treatment with chemical nail avulsion with RV4104A...

...M. Lahfa; C. Bulai-Livideanu; R. Baran; J.P. Ortonne; B. Richert; A. Tosti; B.M. Piraccini; J.C. Szepietowski; V. Sibaud; H. Coubetergues; J.J. Voisard; C. Paul Background: Toenail onychomycosis is highly prevalent, with 14-28% of people aged 60 or over suffering from the disease. Use of a topical...

...Massimo Lurati; Florence Baudraz-Rosselet; Maxime Vernez; Phillip Spring; Olympia Bontems; Marina Fratti; Michel Monod Background: Dermatophytes are the main cause of onychomycosis, but various non-dermatophyte moulds (NDMs) are often the infectious agents in abnormal nails. In particular, Fusarium...

... patients (six 40- to 50-year-old women and two 30- and 33-year-old men) without diabetes mellitus or any other dermatological or vascular disease were referred to one of us (F.B.R.) for treatment of a persistent onychomycosis without improvement despite multiple previous antifungal treatments. All...

...Per Onsberg Scopulariopsis brevicaulis was demonstrated in 226 out of 5,600 patients examined for abnormal toe-nails. Among 3,700 patients without onychomycosis S. brevicaulis was demonstrated as a contaminant in 2%. Onychomycosis, present in 1,925 patients, was caused by S. brevicaulis in 6...

...Per Onsberg; Dorrit Stahl 7 patients with Scopulariopsis brevicaulis onychomycosis of the toe-nails were treated locally with 1% natamycin in 60% dimethylsulphoxide. After 3–5 months treatment the fungus could no longer be isolated from the nails, and at follow-up 15 months after the completion...

...D. Van Neste; G. Minne; P. Thomas; X. Gosselin Hyperkeratotic scabies and onychomycosis were associated in an immunosuppressed patient. Onychomycosis healed spontaneously after treatment of scabies. A possible interrelationship between Sarcoptes scabiei infestation of the hyponychium...

...Masamitsu Ishii; Toshio Hamada; Yoshie Asai 20 patients with distal onychomycosis were given daily application of an ointment containing 2% tolnaftate and an ointment containing 20% urea under ODT. Following this, 17 of 20 patients developed onychomalacia and seven of these developed onycholysis 1...

...H. Fritsch; S. Stettendorf; L. Hegemann In the present study, we investigated the effects of bifonazole/urea ointment, a novel topical drug for the treatment of onychomycosis, on the ultrastructure of normal and fungus-infected human toenails by scanning electron microscopy. Nails were treated...

...D. Reinel 456 patients with onychomycosis were treated once or twice weekly for up to 6 months with amorolfine 5% nail lacquer in an open, randomized study. The patients were examined at monthly intervals during treatment and followed-up 1 and 3 months after completion of treatment. Slightly better...

...G.T. Nahass; M. Sisto We report a case of fingernail onychomycosis in an immunosuppressed renal transplant patient who was successfully treated with once-weekly fluconazole therapy. Relapse did not develop over the 2-month follow-up period. There were no adverse effects from therapy...

...E.K.A. Van Doorslaer; G. Tormans; A.K. Gupta; K. Van Rossem; A. Eggleston; D.J. Dubois; P. De Doncker; E. Haneke Background : The strategies for the management of onychomycosis have changed since the availability of the newer generation of antifungal agents, particularly, itraconazole...